This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nagao, M. Articles by Okada, M. Search for Related Content PubMed PubMed Citation Articles by Nagao, M. Articles by Okada, M.

Mutagenicity of N-Butyl-N-(4-hydroxybutyl)nitrosamine, a Bladder Carcinogen, and Related Compounds¹

Biochemistry Division, National Cancer Canter Research Institute, Tsukiji 5-1-1, Chuo-ku, Tokyo 104 [M. N., K. Y., T. Y., Y. S., T. S.], and Tokyo Biochemical Research Institute, Takada 3-41-8, Toshima-ku, Tokyo 171, Japan [E. S., M. O.]

N-Butyl-N-(4-hydroxybutyl)nitrosamine (BBN), which specifically induces bladder tumors, was shown to be mutagenic to Salmonella typhimurium strains TA1535 and TA100 in the presence of an S-9 mix prepared from the liver of rats treated with polychlorinated biphenyl. Reduced nicotinamide adenine dinucleotide was a more effective cofactor than reduced nicotinamide adenine dinucleotide phosphate in the activation of BBN by the rat liver S-9 fraction. N-Butyl-N-(3-carboxypropyl)nitrosamine, reported to be the main urinary metabolite of BBN as well as of N,N-dibutylnitrosamine and to induce urinary bladder tumors specifically, was found to be mutagenic without metabolic activation by the S-9 mix.

The mutagenicities of 31 compounds related structurally or metabolically to BBN and N,N-dibutylnitrosamine were tested. Of these compounds, 13 have previously been demonstrated to be carcinogenic, and nine have been shown to be noncarcinogenic. All the carcinogenic compounds were found to be mutagenic to strain TA1535 with or without the S-9 mix. Four of the nine noncarcinogenic compounds were also mutagenic. These "false-positive" compounds were predicted, in fact, to be carcinogenic.

¹ Supported in part by grants from the Ministry of Health and Welfare, the Ministry of Education, Science and Culture, and the Society for Promotion of Cancer Research, Japan.

Received 7/ 1/76. Accepted 10/28/76.

This article has been cited by other articles:

				Y. Mori, A. Koide, K. Fuwa, H. Wanibuchi, and S. Fukushima Lack of change in the levels of liver and kidney cytochrome P-450 isozymes in p53(+/-) knockout mice treated with N-butyl-N-(4-hydroxybutyl)nitrosamine Mutagenesis, September 1, 2001; 16(5): 377 - 383. [Abstract] [Full Text] [PDF]